When will Israeli biotech grow up?
Article Abstract:
Israel's creativity in the life sciences is doubtful, much of which comes from the country's seven major academic institutions, though investors are cautious of the apparent lack of ability to turn all the intellectual property into biotechnology products. The Israeli government and venture capitalists need to do more to fund biotech start-up companies in an effort to boost the country's biotech prospects, assert industry watchers.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Dow pulls out of bioplastics due to slow sector maturation
Article Abstract:
Chemical giant Dow declared that it was pulling out of a large investment in the agricultural and industrial company Minnesota-based Cargill since it might take longer than expected time to bring a return on investment. The joint venture between Cargill and Dow Chemical was set up to commercialize polyactic acid (PLA) under the brand name Nature Works.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
First inhalable insulin approved
Article Abstract:
Exubera, the inhalable insulin made by Nektar Therapeutics, the San Francisco-based company is approved in both the United States and Europe in January 2006. Exubera offers diabetics an alternative to traditional needle-based delivery.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Where have all the antibiotic patents gone? Fishing for cancer models
- Abstracts: Genta sued over NDA withdrawal. Maturing biotechs turn to pharma's markets. Redesigner drugs
- Abstracts: Pantene Pro-V Full & Thick Hair Styling Products. Ampro Purple Rain Styling Gel. Activate Beauty Hair Care Products
- Abstracts: Harvey: Army will directly compete tested FCS technologies. Analyst: FCS offers 'lots of business opportunities'
- Abstracts: Harvey defends sending Humvees to Fort Hood: Tech installation faster at home, Secretary says. Army seeks waiver for swift buy of 6000 Raytheon radios